ʻO ka Hormone Hoʻoikaika i ka Thyroid (TSH) Immunofluorescence Assay: Comprehensive Thyroid Health Management with Integrated FT4/FT3 Testing
TSH-FT4-FT3: Ka Triad Gula no ka Loiloi Hana Hana
ʻO ka Thyroid-Stimulating Hormone (TSH), ka mea hoʻoponopono kikowaena o ka axis pituitary-thyroid, e lawelawe nei ma ke ʻano he "hōʻailona mua" no ka hana ʻino thyroid. ʻO Thyroxine Free (FT4) a me Free Triiodothyronine (FT3), e hōʻike pololei ana i ka bioactivity o nā hormones thyroid, e hana i kahi triad diagnostic koʻikoʻi me TSH. ʻO ka hoʻāʻo ʻana o kēia mau biomarkers ʻekolu e hiki ai i ka loiloi piha ʻana i ke kūlana thyroid, ka hoʻokaʻawale pololei ʻana o nā maʻi mua, lua, a me nā maʻi subclinical, a me ke kākoʻo paʻa no ka hoʻoholo ʻana i ka lāʻau lapaʻau.

Nā Hoʻopiʻi Hoʻonaʻauao Hoʻonaʻauao
- Hoʻokaʻawale pololei ʻana o ka maʻi thyroid:
TSH + FT4 Synergy: ʻO ka TSH kiʻekiʻe me ka FT4 i hoʻemi ʻia e hōʻoia i ka hypothyroidism mua (ʻike >98%), ʻoiai ke kāohi ʻia ʻo TSH me ka FT4 kiʻekiʻe e hōʻike ana i ka thyrotoxicosis (e laʻa, ka maʻi Graves).
TSH + FT3 Dynamic Monitoring: Hōʻike ka FT3 i ka ʻike kiʻekiʻe no ka ʻike mua ʻana i ka hyperthyroidism. TSH 6.5 pmol/L Akāclitates i ka ʻike wikiwiki ʻana i ka T3-predominant thyrotoxicosis, e hōʻemi ana i nā maʻi i hala ʻole.
- ʻO ka nānā ʻana i nā neonatal no ka Hypothyroidism Congenital a me nā maʻi kū'ē:
ʻO Hypothyroidism Congenital: TSH ≥10 mIU/L me FT4 ʻIkepili.
ʻO ka Hormone Resistance (RTH): ʻO TSH kiʻekiʻe me ka FT4 maʻamau e pono ai ka loiloi RTH e pale i ka misdiagnosis.
- Ka nānā 'ana i ka lapa'au pilikino:
Hoʻokele Hyperthyroidism: ʻO ka hoʻāʻo ʻana o TSH, FT3, a me FT4 me ka ikaika e hahai i ka pono o ka lāʻau antithyroid (nā pahuhopu: TSH 0.4-2.0 mIU/L, FT4 10-20 pmol/L), e pale ana i ka hypothyroidism i hoʻoulu ʻia.
ʻO ka Hypothyroidism Therapy: Hoʻohui ʻia ka hoʻonui ʻia ʻana o Levothyroxine i ka TSH (pahu: 0.5-3.0 mIU/L) a me nā pae FT4 (12-22 pmol/L) no ka hoʻololi ʻana i ka hormone pololei.
- ʻO ka hoʻokele thyroid i ka hāpai ʻana:
ʻO ka Hypothyroidism: ʻO TSH ≥2.5 mIU/L me FT4 ma lalo o nā pae kuhikuhi kikoʻī o ka trimester e hōʻoia i ka hana koke.
Hoʻokaʻawale Hypothyroxinemia: ʻO ka TSH maʻamau me ka FT4 haʻahaʻa hiki ke hōʻike i ka pilikia o ka hānau ʻana, pono ke loiloi antibody TPO.
- ʻIke ʻokoʻa o nā maʻi endocrine paʻakikī:
Central Hypothyroidism: TSH maʻamau/haʻahaʻa me ka FT4 hoʻemi.
ʻO ka maʻi Thyroid Subclinical: TSH kūponoʻole me ka FT4/FT3 maʻamau, e koi ana i ka hahai lōʻihi.
Non-Thyroidal Illness Syndrome (NTIS): ʻO ka FT3 haʻahaʻa loa me ka TSH maʻamau e hōʻike ana i ka maʻi koʻikoʻi.
aehealth Ka Papahana Immunofluorescence: Ho'āʻo Nui-Parameter, Ponoʻole

Lamuno X: 10 Kanika Hana

Lamuno Pro: 12 Kūʻokoʻa hana Channels

Lamuno Plus: Hoʻohana ʻia nā ʻano he nui
ʻIke ʻana i nā ʻāpana he nui: TSH, FT4, a me FT3 i nā minuke 15 me ka hoʻāʻo hoʻokahi.
Laulā laina:
TSH 0.1-100 mIU/mL, FT4 0.3-100 pmol/L, FT3 0.4-50 pmol/L, e uhi ana i ka nānā ʻana i nā pono mālama koʻikoʻi.
ʻOi aku ka maikaʻi o ka hana: Sensitivity o 0.01 mIU / mL (TSH) a me 0.5 pmol / L (FT4 / FT3);
ʻIkepili akamai: Hoʻololi ʻokoʻa i nā manawa kuhikuhi no ka hāpai ʻana a me nā pūʻulu makahiki, me nā ʻike lapaʻau i alakaʻi ʻia e AI no ka hoʻoholo ʻana i ka hoʻoholo.
Hoʻoikaika i ka lāʻau lapaʻau pololei, mālama i ke olakino thyroid
Hoʻololi hou ʻo Aehealth i nā diagnostics thyroid ma o ka hoʻohui ʻana i ka hoʻāʻo TSH, FT4, a me FT3 i kahi kahua hoʻokahi. Hoʻonui kēia hāʻina holoʻokoʻa i ka pololei diagnostic, hōʻemi i nā hewa lapaʻau, a kākoʻo i ka hoʻokele maʻi hope-a-hope-mai ka nānā ʻana i ka nānā ʻana i ka wā lōʻihi-hiki i nā mea mālama ola ke hāʻawi i ka mālama thyroid maikaʻi.


Kelepona
Hoʻouna leka uila
whatsapp
Facebook
Youtube





